Ting Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ting Guo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Aiyan Zhang
Department of Pneumology The Second Hospital of Hebei Medical University Shijiazhuang 050000 China hebmu.edu.cn
1 shared publication - Lining Huang
Department of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
1 shared publication - Peiying Huang
Postdoctoral Mobile Station The Second Hospital of Hebei Medical University Shijiazhuang Hebei China
1 shared publication - Sichen Cui
Department of Anesthesiology The Second Hospital of Hebei Medical University Shijiazhuang 050000 China hebmu.edu.cn
1 shared publication - Ya Li
Affiliation Department of Ornamental Plant Research Center, Institute of Botany, Jiangsu Province and Chinese Academy of Sciences, Nanjing, China
1 shared publication Zeyu Tian
Heilongjiang Institute of Technology,College of Surveying and Mapping,Harbin,China
1 shared publication
Latest Publications
- Open Access
- 11 December 2023
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2023, 1-8
Esketamine Combined with Propofol TCI versus Propofol TCI for Deep Sedation during Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A Prospective, Randomized, and Controlled Trial
Background. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an invasive procedure that required deep sedation to suppress coughing and body movements. Deep sedation, on the other hand, has been shown to cause respiratory and circulatory depression, especially when the airway is shared with the endoscopist. Esketamine is a novel sedative and analgesic with little respiratory inhibition that appears to be an appropriate adjuvant in propofol sedation for EBUS-TBNA. We compared the efficacy and safety of esketamine combined with propofol target-controlled infusion (TCI) and propofol TCI for deep sedation in EBUS-TBNA. Methods. The study included 135 patients with ASA II-III undergoing EBUS-TBNA. They were randomly divided into two groups (group E and group P). Both groups received midazolam (0.01–0.03 mg/kg) and oxycodone (0.07–0.08 mg/kg). Then, patients in group E received 0.3 mg/kg esketamine, propofol TCI, and 0.2 mg·kg−1·h−1 esketamine for sedative maintenance. Patients in group P received only propofol TCI. The primary outcome was the dose of 1% lidocaine administrated by the endoscopist and the times of lidocaine sprays. Secondary outcome indicators were cough score, propofol dosage, patient satisfaction, endoscopist satisfaction, the incidence of sedation-related adverse effects and side effects, and recovery time. Results. Patients in group E were given significantly less lidocaine (4.36 ml/h (2.67–6.00) vs 6.00 ml/h (4.36–7.20), ) and less spraying frequency (2.18 times/h (1.33–3.00) vs 3.00 times/h (2.18–3.60), ) than group P. There was a statistically significant difference in cough score between the two groups (group E 2 (0–4) vs group P 3 (2–4), ). Also, mean arterial pressure (MAP) was higher in group E in the 30th min (T5, 84.10 ± 12.91 mmHg versus 79.04 ± 10.01 mmHg, ) and 40th min (T6, 87.72 ± 15.55 mmHg versus 82.14 ± 10.51 mmHg, ). There were no significant differences between the two groups in terms of sedation-related adverse events and side effects, recovery time, endoscopist satisfaction, and patient satisfaction. Conclusions. In patients with ASA II-III, esketamine as an adjuvant in combination with propofol TCI deep sedation for EBUS-TBNA can improve the sedation effect, reduce coughing reaction during the procedure, and obtain more stable blood pressure. No reduction in the occurrence of sedation-related side effects was observed. This trial is registered with ChiCTR2200061124.
- 11 December 2023
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2023, 1-8
Open AccessEsketamine Combined with Propofol TCI versus Propofol TCI for Deep Sedation during Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A Prospective, Randomized, and Controlled Trial
Background. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an invasive procedure that required deep sedation to suppress coughing and body movements. Deep sedation, on the other hand, has been shown to cause respiratory and circulatory depression, especially when the airway is shared with the endoscopist. Esketamine is a novel sedative and analgesic with little respiratory inhibition that appears to be an appropriate adjuvant in propofol sedation for EBUS-TBNA. We compared the efficacy and safety of esketamine combined with propofol target-controlled infusion (TCI) and propofol TCI for deep sedation in EBUS-TBNA. Methods. The study included 135 patients with ASA II-III undergoing EBUS-TBNA. They were randomly divided into two groups (group E and group P). Both groups received midazolam (0.01–0.03 mg/kg) and oxycodone (0.07–0.08 mg/kg). Then, patients in group E received 0.3 mg/kg esketamine, propofol TCI, and 0.2 mg·kg−1·h−1 esketamine for sedative maintenance. Patients in group P received only propofol TCI. The primary outcome was the dose of 1% lidocaine administrated by the endoscopist and the times of lidocaine sprays. Secondary outcome indicators were cough score, propofol dosage, patient satisfaction, endoscopist satisfaction, the incidence of sedation-related adverse effects and side effects, and recovery time. Results. Patients in group E were given significantly less lidocaine (4.36 ml/h (2.67–6.00) vs 6.00 ml/h (4.36–7.20), ) and less spraying frequency (2.18 times/h (1.33–3.00) vs 3.00 times/h (2.18–3.60), ) than group P. There was a statistically significant difference in cough score between the two groups (group E 2 (0–4) vs group P 3 (2–4), ). Also, mean arterial pressure (MAP) was higher in group E in the 30th min (T5, 84.10 ± 12.91 mmHg versus 79.04 ± 10.01 mmHg, ) and 40th min (T6, 87.72 ± 15.55 mmHg versus 82.14 ± 10.51 mmHg, ). There were no significant differences between the two groups in terms of sedation-related adverse events and side effects, recovery time, endoscopist satisfaction, and patient satisfaction. Conclusions. In patients with ASA II-III, esketamine as an adjuvant in combination with propofol TCI deep sedation for EBUS-TBNA can improve the sedation effect, reduce coughing reaction during the procedure, and obtain more stable blood pressure. No reduction in the occurrence of sedation-related side effects was observed. This trial is registered with ChiCTR2200061124.
- 29 January 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 529-533
Research on Semantic Segmentation of Airborne LiDAR Point Cloud Based on Spatial Position Attention Mechanism
Airborne lidar detection technology can quickly and efficiently observe the earth, actively, real-time and directly obtain the three-dimensional information of a large range of ground objects, and generate a large range of LiDAR point clouds. However, complex categories and uneven heights of ground objects lead to difficulty on the semantic segmentation. To overcome this difficulty, this paper proposes an new semantic segmentation network for point clouds based on the spatial position attention mechanism and deep learning network. This network can directly process original point cloud without converting the original point cloud data into groups of 2D feature images or 3D voxel grids, avoiding information loss. The semantic segmentation model uses the encoder and decoder to extract multiple scale features, and uses the multiple layer perceptron to realize high precision segmentation. By the spatial position attention mechanism, this network can strengthen or weaken weights of the convolution kernel to automatically adapt to spatial structures of point cloud objects. In this paper, the ISPRS dataset provided by the International Society for Photogrammetry and Remote Sensing is used to carry out experiments. The experiment results indicate the proposed network can effectively identify various ground objects and has higher semantic segmentation accuracy than other popular methods.
- 29 January 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 529-533
Research on Semantic Segmentation of Airborne LiDAR Point Cloud Based on Spatial Position Attention Mechanism
Airborne lidar detection technology can quickly and efficiently observe the earth, actively, real-time and directly obtain the three-dimensional information of a large range of ground objects, and generate a large range of LiDAR point clouds. However, complex categories and uneven heights of ground objects lead to difficulty on the semantic segmentation. To overcome this difficulty, this paper proposes an new semantic segmentation network for point clouds based on the spatial position attention mechanism and deep learning network. This network can directly process original point cloud without converting the original point cloud data into groups of 2D feature images or 3D voxel grids, avoiding information loss. The semantic segmentation model uses the encoder and decoder to extract multiple scale features, and uses the multiple layer perceptron to realize high precision segmentation. By the spatial position attention mechanism, this network can strengthen or weaken weights of the convolution kernel to automatically adapt to spatial structures of point cloud objects. In this paper, the ISPRS dataset provided by the International Society for Photogrammetry and Remote Sensing is used to carry out experiments. The experiment results indicate the proposed network can effectively identify various ground objects and has higher semantic segmentation accuracy than other popular methods.